Use of microRNA to identify stage IV breast cancer patients to be targeted with phospholipase A2 disrupted cisplatin carrying liposomes: An ongoing phase I trial

Autor:	Peter Buhl Jensen, Iben Kümler, Nils Brünner, Ulla Hald Buhl, Steen Knudsen, Peter Michael Vestlev, Anker Jon Hansen, Dorte Nielsen, Eva Balslev, Bent Ejlertsen, Ulrik Lassen, Anne Vibeke Lænkholm, Thomas Jensen, Ida Kappel Buhl, Morten Mau Soerensen, Pernille Braemer Hertel, Mogens Winkel Madsen, Jon Askaa
Rok vydání:	2014
Předmět:	Cisplatin Cancer Research Liposome biology business.industry Bioinformatics medicine.disease Phospholipase A2 Breast cancer Oncology microRNA Toxicity Cancer research biology.protein Medicine skin and connective tissue diseases Stage iv business medicine.drug
Zdroj:	Journal of Clinical Oncology. 32:TPS1139-TPS1139
ISSN:	1527-7755 0732-183X
Popis:	TPS1139 Background: Cisplatin has shown activity in BRCA associated breast cancer patients but generally the use of cisplatin in breast cancer has been hampered by high toxicity and low response ra...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::301273b5f11915ac315c1de8332b9fd7 https://doi.org/10.1200/jco.2014.32.15_suppl.tps1139 Zobrazit plný text záznamu